Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3389/fimmu.2018.00835 http://scihub22266oqcxt.onion/10.3389/fimmu.2018.00835 C5924791!5924791!29740441     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Front+Immunol 2018 ; 9 (ä): ä Nephropedia Template TP {{tp|p=29740441|t=2018. Targeting B Cells and Plasma Cells in Autoimmune Diseases |pdf=|usr=}}{{29740441}} gab.com Text Targeting B Cells and Plasma Cells in Autoimmune Diseases JO: Front Immunol http://www.kidney.de/pget.php?&tw=1&pmid=29740441 #FOAvip Success with B cell depletion using rituximab has proven the concept that B lineage cells represent a valid target for the treatment of autoimmune diseases, and has promoted the development of other B cell targeting agents. Present data confirm that B cell depletion is beneficial in various autoimmune disorders and also show that it can worsen the disease course in some patients. These findings suggest that B lineage cells not only produce pathogenic autoantibodies, but also significantly contribute to the regulation of inflammation. In this review, we will discuss the multiple pro- and anti-inflammatory roles of B lineage cells play in autoimmune diseases, in the context of recent findings using B lineage targeting therapies. Twit Text FOAVip Targeting B Cells and Plasma Cells in Autoimmune Diseases ????Front Immunol http://www.kidney.de/pget.php?&tw=1&pmid=29740441 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29740441 #FOAvip English Wikipedia <ref>{{Cite pmid|29740441}}</ref> Targeting B Cells and Plasma Cells in Autoimmune Diseases #MMPMID29740441 Hofmann K; Clauder AK; Manz RA Front Immunol 2018[]; 9 (ä): ä PMID29740441show ga Success with B cell depletion using rituximab has proven the concept that B lineage cells represent a valid target for the treatment of autoimmune diseases, and has promoted the development of other B cell targeting agents. Present data confirm that B cell depletion is beneficial in various autoimmune disorders and also show that it can worsen the disease course in some patients. These findings suggest that B lineage cells not only produce pathogenic autoantibodies, but also significantly contribute to the regulation of inflammation. In this review, we will discuss the multiple pro- and anti-inflammatory roles of B lineage cells play in autoimmune diseases, in the context of recent findings using B lineage targeting therapies. äTargeting B Cells and Plasma Cells in Autoimmune Diseases (epmc).pdf DeepDyve Pubget Overpricing